Literature DB >> 14677027

Visceral leishmaniasis resembling systemic lupus erythematosus.

Michalis Voulgarelis1, Paraskevi V Voulgari, John Serelis, Alexandros A Drosos, Fotini N Skopouli.   

Abstract

We describe three cases with visceral leishmaniasis (VL) associated with autoimmune manifestations. The patients presented with anemia, leukopenia, thrombocytopenia, renal involvement and low complement levels. Autoimmune features were present (antinuclear and anticardiolipin antibodies, VDRL, RF, positive direct Coombs' test), which subsided after therapy. Leishmaniasis should be taken into consideration in the differential diagnosis of autoimmune disorders.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14677027     DOI: 10.1007/s10067-003-0773-7

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  17 in total

Review 1.  How do protozoan parasites survive inside macrophages?

Authors:  C Bogdan; M Röllinghoff
Journal:  Parasitol Today       Date:  1999-01

2.  Anaemia in systemic lupus erythematosus: aetiological profile and the role of erythropoietin.

Authors:  M Voulgarelis; S I Kokori; J P Ioannidis; A G Tzioufas; D Kyriaki; H M Moutsopoulos
Journal:  Ann Rheum Dis       Date:  2000-03       Impact factor: 19.103

3.  Autoantibody production by patients infected with Leishmania.

Authors:  S Argov; C L Jaffe; M Krupp; H Slor; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  1989-05       Impact factor: 4.330

4.  Hematologic aspects of systemic lupus erythematosus. Current concepts.

Authors:  D R Budman; A D Steinberg
Journal:  Ann Intern Med       Date:  1977-02       Impact factor: 25.391

5.  Autoimmune hemolytic anemia in patients with systemic lupus erythematosus.

Authors:  S I Kokori; J P Ioannidis; M Voulgarelis; A G Tzioufas; H M Moutsopoulos
Journal:  Am J Med       Date:  2000-02-15       Impact factor: 4.965

6.  Crossing of antinuclear antibodies and anti-leishmania antibodies.

Authors:  B Granel; J Serratrice; L Swiader; F Gambarelli; L Daniel; C Fossat; S Hesse-Bonérandi; X Pache; P Disdier; P J Weiller
Journal:  Lupus       Date:  2000       Impact factor: 2.911

7.  Mixed cryoglobulinemia secondary to visceral Leishmaniasis.

Authors:  M Casato; F G de Rosa; L P Pucillo; I Ilardi; B di Vico; L R Zorzin; M L Sorgi; P Fiaschetti; R Coviello; B Laganà; M Fiorilli
Journal:  Arthritis Rheum       Date:  1999-09

Review 8.  The regulation of immunity to Leishmania major.

Authors:  S L Reiner; R M Locksley
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

9.  High C-reactive protein response in lupus polyarthritis.

Authors:  H M Moutsopoulos; A K Mavridis; N C Acritidis; P C Avgerinos
Journal:  Clin Exp Rheumatol       Date:  1983 Jan-Mar       Impact factor: 4.473

10.  Switch from a type 2 to a type 1 T helper cell response and cure of established Leishmania major infection in mice is induced by combined therapy with interleukin 12 and Pentostam.

Authors:  G S Nabors; L C Afonso; J P Farrell; P Scott
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

View more
  2 in total

1.  Cryoglobulinemic purpura in visceral leishmaniasis.

Authors:  Evangelos Rizos; George Dimos; Evangelos N Liberopoulos; Moses S Elisaf; Alexandros A Drosos
Journal:  Rheumatol Int       Date:  2004-11-10       Impact factor: 2.631

2.  Visceral leishmaniasis: A case report.

Authors:  Sachin Gawade; Mangesh Nanaware; Rm Gokhale; Ps Adhav
Journal:  Australas Med J       Date:  2012-02-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.